Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Non-Current Deffered Revenue (2010 - 2026)

Omnicell's (OMCL) quarterly Non-Current Deffered Revenue came in at $59.5 million in Q2 2026, down 26.02% year-over-year from $80.4 million in Q2 2025, and down 5.63% quarter-over-quarter from $63.1 million in Q1 2026.

Analysis

Omnicell (OMCL) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Non-Current Deffered Revenue for 17 consecutive years, with $59.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Deffered Revenue fell 26.02% year-over-year to $59.5 million in Q2 2026; TTM through Jun 2026 was $59.5 million, a 26.02% decrease from a year earlier, with the FY2025 full-year figure at $63.3 million, down 16.91% from the prior year.
  • Non-Current Deffered Revenue was $59.5 million for Q2 2026 at Omnicell, down from $63.1 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $80.4 million in Q2 2025 and troughed at $24.0 million in Q1 2022.
  • A 5-year average of $56.4 million and a median of $61.3 million in 2026 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue surged 204.27% in 2022 and decreased 26.02% in 2026, its largest moves.
  • Over 5 years, Non-Current Deffered Revenue stood at $37.4 million in 2022, then soared by 56.81% to $58.6 million in 2023, then climbed by 29.85% to $76.1 million in 2024, then fell by 16.91% to $63.3 million in 2025, then dropped by 5.91% to $59.5 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $59.5 million (Q2 2026), $63.1 million (Q1 2026), and $63.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 170.95 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 59.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.52 Mn
Mar 31, 2026 63.07 Mn
Dec 31, 2025 63.25 Mn
Sep 30, 2025 66.72 Mn
Jun 30, 2025 80.45 Mn
Mar 31, 2025 78.37 Mn
Dec 31, 2024 76.12 Mn
Sep 30, 2024 69.81 Mn
Jun 30, 2024 67.93 Mn
Mar 31, 2024 65.20 Mn
Dec 31, 2023 58.62 Mn
Sep 30, 2023 55.10 Mn
Jun 30, 2023 48.80 Mn
Mar 31, 2023 42.44 Mn
Dec 31, 2022 37.39 Mn
Sep 30, 2022 34.52 Mn
Jun 30, 2022 24.20 Mn
Mar 31, 2022 24.04 Mn
Dec 31, 2021 20.20 Mn
Sep 30, 2021 14.14 Mn